OBJECTIVE: Rhinoviruses (RV), which are responsible for the majority of common colds, induce mucus overproduction, increased vascular permeability, and secondary bacterial infection. These symptoms are primarily caused by barrier function disruption, which is controlled by intercellular junctions. In this study, we investigated whether reactive oxygen species (ROS) are closely involved in tight junction disruption of primary human nasal epithelial (HNE) cells induced by infection of RV . METHODS AND RESULTS: Incubation with RV resulted in disruption of tight junction proteins (ZO-1, E-cadherin, claudin-1, and occludin) in HNE cells. Pretreatment with diphenylene iodonium (DPI) decreased RV-induced disruption of tight junction in HNE cells. RV-induced generation of ROS was diminished by DPI. However, rotenone was not inhibited in HNE cells following incubation with RV. Rhinoviruses resulted in a marked decrease in protein phosphatases activity and an increase in protein tyrosine phosphorylation levels in HNE cells. Diphenylene iodonium inhibited the RV-induced inactivation of phosphatases and phosphorylation of protein tyrosine. In addition, inhibition of protein tyrosine phosphatases with phenylarsine oxide resulted in a marked decrease in protein phosphatase activity and disruption of tight junction proteins in HNE cells. CONCLUSION: Our results suggest that ROS-mediated inhibition of phosphatases plays a crucial role in disruption of tight junctions in HNE cells by RV. The data suggest that RV infection may damage nasal epithelial barrier function. LEVEL OF EVIDENCE: NA Laryngoscope, 128:E393-E401, 2018.
OBJECTIVE: Rhinoviruses (RV), which are responsible for the majority of common colds, induce mucus overproduction, increased vascular permeability, and secondary bacterial infection. These symptoms are primarily caused by barrier function disruption, which is controlled by intercellular junctions. In this study, we investigated whether reactive oxygen species (ROS) are closely involved in tight junction disruption of primary human nasal epithelial (HNE) cells induced by infection of RV . METHODS AND RESULTS: Incubation with RV resulted in disruption of tight junction proteins (ZO-1, E-cadherin, claudin-1, and occludin) in HNE cells. Pretreatment with diphenylene iodonium (DPI) decreased RV-induced disruption of tight junction in HNE cells. RV-induced generation of ROS was diminished by DPI. However, rotenone was not inhibited in HNE cells following incubation with RV. Rhinoviruses resulted in a marked decrease in protein phosphatases activity and an increase in protein tyrosine phosphorylation levels in HNE cells. Diphenylene iodonium inhibited the RV-induced inactivation of phosphatases and phosphorylation of protein tyrosine. In addition, inhibition of protein tyrosine phosphatases with phenylarsine oxide resulted in a marked decrease in protein phosphatase activity and disruption of tight junction proteins in HNE cells. CONCLUSION: Our results suggest that ROS-mediated inhibition of phosphatases plays a crucial role in disruption of tight junctions in HNE cells by RV. The data suggest that RV infection may damage nasal epithelial barrier function. LEVEL OF EVIDENCE: NA Laryngoscope, 128:E393-E401, 2018.
Authors: Erin J Plosa; John T Benjamin; Jennifer M Sucre; Peter M Gulleman; Linda A Gleaves; Wei Han; Seunghyi Kook; Vasiliy V Polosukhin; Scott M Haake; Susan H Guttentag; Lisa R Young; Ambra Pozzi; Timothy S Blackwell; Roy Zent Journal: JCI Insight Date: 2020-01-30
Authors: Kai Sen Tan; Rachel Liyu Lim; Jing Liu; Hsiao Hui Ong; Vivian Jiayi Tan; Hui Fang Lim; Kian Fan Chung; Ian M Adcock; Vincent T Chow; De Yun Wang Journal: Front Cell Dev Biol Date: 2020-02-25
Authors: Yunying Huang; Hana Jedličková; Yang Cai; Ambreen Rehman; Luke Gammon; Usama Sharif Ahmad; Jutamas Uttagomol; Eric Kenneth Parkinson; Farida Fortune; Hong Wan Journal: Front Immunol Date: 2021-04-19 Impact factor: 7.561
Authors: Alexandra R Harris; Savieay Esparza; Mohammad S Azimi; Robert Cornelison; Francesca N Azar; Danielle C Llaneza; Maura Belanger; Alexander Mathew; Svyatoslav Tkachenko; Matthew J Perez; Claire Buchta Rosean; Raegan R Bostic; R Chase Cornelison; Kinsley M Tate; Shayn M Peirce-Cottler; Cherie Paquette; Anne Mills; Charles N Landen; Jeff Saucerman; Patrick M Dillon; Rebecca R Pompano; Melanie A Rutkowski; Jennifer M Munson Journal: Front Oncol Date: 2022-03-17 Impact factor: 5.738
Authors: Siti Muhamad Nur Husna; Hern-Tze Tina Tan; Norasnieda Md Shukri; Noor Suryani Mohd Ashari; Kah Keng Wong Journal: Front Immunol Date: 2021-05-21 Impact factor: 7.561